分组1 - RadNet reported quarterly earnings of $0.23 per share, exceeding the Zacks Consensus Estimate of $0.19 per share, and showing an increase from $0.22 per share a year ago, resulting in an earnings surprise of +22.67% [1] - The company achieved revenues of $547.71 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 6.28%, and up from $477.1 million year-over-year [2] - Over the last four quarters, RadNet has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] 分组2 - The stock has underperformed the market with a loss of about 2.2% since the beginning of the year, compared to the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $533.53 million, and for the current fiscal year, it is $0.73 on revenues of $2.26 billion [7] - The Zacks Industry Rank for Medical - Outpatient and Home Healthcare is currently in the bottom 27% of over 250 Zacks industries, indicating potential challenges for the sector [8]

分组1 - Oportun Financial Corporation reported quarterly earnings of $0.27 per share, exceeding the Zacks Consensus Estimate of $0.26 per share, but down from $0.49 per share a year ago, resulting in an earnings surprise of +3.85% [1] - The company achieved revenues of $247.7 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.40%, although this is a decrease from year-ago revenues of $250.9 million [2] - Oportun Financial has outperformed the S&P 500 with a share price increase of about 4.2% since the beginning of the year, compared to the S&P 500's gain of 1.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.27 on revenues of $238.11 million, and for the current fiscal year, it is $1.43 on revenues of $972.14 million [7] - The Zacks Industry Rank for Financial - Miscellaneous Services is in the top 35% of over 250 Zacks industries, indicating that the industry outlook can significantly impact stock performance [8]

Installed Building Products (IBP) came out with quarterly earnings of $3.24 per share, beating the Zacks Consensus Estimate of $2.8 per share. This compares to earnings of $2.9 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +15.55%. A quarter ago, it was expected that this residential insulation installer would post earnings of $2.69 per share when it actually produced earnings of $3.18, delivering a surprise of +18.22%.Over ...

Option Care (OPCH) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.63%. A quarter ago, it was expected that this infusion and home care services company would post earnings of $0.43 per share when it actually produced earnings of $0.45, delivering a surprise of +4.65%.Over the last four quarter ...

分组1 - GeneDx Holdings Corp. reported quarterly earnings of $0.14 per share, exceeding the Zacks Consensus Estimate of $0.11 per share, and showing a year-over-year decrease from $0.7 per share [1] - The company achieved revenues of $120.99 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.50% and increasing from $95.64 million year-over-year [2] - GeneDx Holdings has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has underperformed, losing approximately 36.9% since the beginning of the year, while the S&P 500 has gained 0.9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.09 on revenues of $115.8 million, and for the current fiscal year, it is $0.58 on revenues of $526.5 million [7] - The Medical Services industry, to which GeneDx belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, which may impact stock performance [8]

Core Viewpoint - CF Industries reported quarterly earnings of $2.99 per share, exceeding the Zacks Consensus Estimate of $2.5 per share, and showing a significant increase from $1.89 per share a year ago, representing an earnings surprise of +19.79% [1] Financial Performance - The company achieved revenues of $1.87 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 4.69%, and up from $1.52 billion in the same quarter last year [2] - Over the last four quarters, CF has consistently surpassed consensus EPS estimates four times and topped revenue estimates three times [2] Stock Performance - CF shares have increased approximately 21.3% since the beginning of the year, in contrast to the S&P 500's zero return [3] Future Outlook - The company's earnings outlook will be crucial for determining the stock's immediate price movement, with current consensus EPS estimates at $1.95 on $1.67 billion in revenues for the upcoming quarter and $7.46 on $6.71 billion in revenues for the current fiscal year [4][7] - The Zacks Rank for CF is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Fertilizers industry, to which CF belongs, is currently ranked in the top 11% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% of industries [8]

分组1 - Tactile Systems Technology (TCMD) reported quarterly earnings of $0.46 per share, exceeding the Zacks Consensus Estimate of $0.44 per share, and showing an increase from $0.40 per share a year ago, representing an earnings surprise of +3.77% [1] - The company achieved revenues of $103.59 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 10.52%, and up from $85.58 million in the same quarter last year [2] - Tactile Systems Technology has outperformed consensus EPS estimates three times over the last four quarters [2] 分组2 - The stock has underperformed the market, losing about 8.8% since the beginning of the year, compared to a decline of 0.1% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.06 on revenues of $68.67 million, and for the current fiscal year, it is $0.97 on revenues of $345.33 million [7] - The Medical - Instruments industry, to which Tactile Systems Technology belongs, is currently ranked in the top 31% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

分组1 - Gilead Sciences reported quarterly earnings of $1.86 per share, exceeding the Zacks Consensus Estimate of $1.83 per share, but down from $1.90 per share a year ago, representing an earnings surprise of +1.91% [1] - The company achieved revenues of $7.93 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 4.63% and up from $7.57 billion year-over-year [2] - Gilead shares have increased approximately 23.6% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.7% [3] 分组2 - The earnings outlook for Gilead is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $1.90 on revenues of $6.84 billion, and for the current fiscal year, it is $8.61 on revenues of $30.04 billion [7] - The Medical - Biomedical and Genetics industry, to which Gilead belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]

Core Viewpoint - MarketAxess reported quarterly earnings of $1.68 per share, exceeding the Zacks Consensus Estimate of $1.66 per share, but down from $1.73 per share a year ago, indicating an earnings surprise of +1.45% [1] Financial Performance - The company posted revenues of $209.41 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 1.55%, compared to $202.4 million in the same quarter last year [2] - Over the last four quarters, MarketAxess has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Stock Performance - MarketAxess shares have declined approximately 10.2% since the beginning of the year, while the S&P 500 has only decreased by 0.7% [3] - The current Zacks Rank for MarketAxess is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $2.06 on revenues of $229.07 million, and for the current fiscal year, it is $8.08 on revenues of $914.6 million [7] - The estimate revisions trend for MarketAxess was mixed ahead of the earnings release, which could change following the recent report [6] Industry Context - The Financial - Investment Bank industry, to which MarketAxess belongs, is currently in the top 17% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - The performance of MarketAxess may be influenced by the overall industry outlook [8]

随着美股财报季的开启，标普500指数在2025年第四季度目前的盈利增速为8.2%，这将是该指数连续第十 个季度实现同比盈利增长。鉴于大多数标普500公司报告的实际盈利高于市场预期，那么该指数在去年四 季度最终录得8.2%的盈利增长，其可能性有多大？ 基于历次财报季中盈利增速的平均上修幅度，我们认为，标普500指数去年四季度很可能至少实现14%的 盈利增长，从而连续第5个季度录得两位数的盈利增速。 首先要明确，当标普500指数公司在财报季公布的实际每股收益（EPS）高于市场预期时，该指数的整体 盈利增速就会上升，因为在增长率计算中，较高的实际EPS数字取代了原先较低的预期收益。举例而言， 某公司预计当季EPS为1.05美元，而去年同期EPS为1.00美元，那么该公司预计将报告5%的盈利增长。如 果该公司最终公布的实际EPS为1.10美元（较预期高出0.05美元），那么该公司当季的实际盈利增速将提 升至10%，比原先的预期增速高出5个百分点（5%+5%=10%）。 事实上，在过去40个季度中，有37个季度标普500指数的实际盈利增速高于季末的预期盈利增速。仅有 2020年第一季度、2022年第三季度和2022年第 ...